Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Should You Buy PRA Health Sciences Inc (PRAH)?

Amid an overall market correction, many stocks that smart money investors were collectively bullish on tanked during the fourth quarter. Among them, Amazon and Netflix ranked among the top 30 picks and both lost around 20%. Facebook, which was the second most popular stock, lost 14% amid uncertainty regarding the interest rates and tech valuations. Nevertheless, our research shows that most of the stocks that smart money likes historically generate strong risk-adjusted returns. This is why following the smart money sentiment is a useful tool at identifying the next stock to invest in.

Is PRA Health Sciences Inc (NASDAQ:PRAH) a cheap investment now? Prominent investors are in a bullish mood. The number of bullish hedge fund bets improved by 3 in recent months. Our calculations also showed that PRAH isn’t among the 30 most popular stocks among hedge funds. PRAH was in 28 hedge funds’ portfolios at the end of the third quarter of 2018. There were 25 hedge funds in our database with PRAH positions at the end of the previous quarter.

In the eyes of most shareholders, hedge funds are perceived as slow, old financial vehicles of years past. While there are over 8,000 funds with their doors open today, We choose to focus on the moguls of this club, about 700 funds. It is estimated that this group of investors command most of the smart money’s total asset base, and by keeping an eye on their finest stock picks, Insider Monkey has uncovered many investment strategies that have historically outstripped Mr. Market. Insider Monkey’s flagship hedge fund strategy beat the S&P 500 index by 6 percentage points per annum since its inception in May 2014 through early November 2018. We were able to generate large returns even by identifying short candidates. Our portfolio of short stocks lost 24% since February 2017 (through December 3rd) even though the market was up nearly 23% during the same period. We just shared a list of 11 short targets in our latest quarterly update.

Kris Jenner - Rock Springs Capital

Let’s take a glance at the fresh hedge fund action surrounding PRA Health Sciences Inc (NASDAQ:PRAH).

How have hedgies been trading PRA Health Sciences Inc (NASDAQ:PRAH)?

At Q3’s end, a total of 28 of the hedge funds tracked by Insider Monkey held long positions in this stock, a change of 12% from one quarter earlier. Below, you can check out the change in hedge fund sentiment towards PRAH over the last 13 quarters. So, let’s find out which hedge funds were among the top holders of the stock and which hedge funds were making big moves.

PRAH_dec2018

Of the funds tracked by Insider Monkey, Brian Ashford-Russell and Tim Woolley’s Polar Capital has the largest position in PRA Health Sciences Inc (NASDAQ:PRAH), worth close to $54.5 million, comprising 0.5% of its total 13F portfolio. Coming in second is Laurion Capital Management, led by Benjamin A. Smith, holding a $53.3 million position; the fund has 0.5% of its 13F portfolio invested in the stock. Some other peers that are bullish include Kris Jenner, Gordon Bussard, Graham McPhail’s Rock Springs Capital Management, Jeremy Green’s Redmile Group and Israel Englander’s Millennium Management.

Now, some big names have jumped into PRA Health Sciences Inc (NASDAQ:PRAH) headfirst. Laurion Capital Management, managed by Benjamin A. Smith, established the most valuable position in PRA Health Sciences Inc (NASDAQ:PRAH). Laurion Capital Management had $53.3 million invested in the company at the end of the quarter. Jeremy Green’s Redmile Group also initiated a $22 million position during the quarter. The following funds were also among the new PRAH investors: John Overdeck and David Siegel’s Two Sigma Advisors, Paul Marshall and Ian Wace’s Marshall Wace LLP, and George Zweig, Shane Haas and Ravi Chander’s Signition LP.

Let’s also examine hedge fund activity in other stocks – not necessarily in the same industry as PRA Health Sciences Inc (NASDAQ:PRAH) but similarly valued. We will take a look at Ionis Pharmaceuticals, Inc. (NASDAQ:IONS), Booz Allen Hamilton Holding Corporation (NYSE:BAH), Kimco Realty Corp (NYSE:KIM), and Commerce Bancshares, Inc. (NASDAQ:CBSH). This group of stocks’ market valuations are similar to PRAH’s market valuation.

Ticker No of HFs with positions Total Value of HF Positions (x1000) Change in HF Position
IONS 22 100135 3
BAH 22 350734 0
KIM 17 66800 -1
CBSH 12 109580 3
Average 18.25 156812 1.25

View table here if you experience formatting issues.

As you can see these stocks had an average of 18.25 hedge funds with bullish positions and the average amount invested in these stocks was $157 million. That figure was $276 million in PRAH’s case. Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) is the most popular stock in this table. On the other hand Commerce Bancshares, Inc. (NASDAQ:CBSH) is the least popular one with only 12 bullish hedge fund positions. Compared to these stocks PRA Health Sciences Inc (NASDAQ:PRAH) is more popular among hedge funds. Considering that hedge funds are fond of this stock in relation to its market cap peers, it may be a good idea to analyze it in detail and potentially include it in your portfolio.

Disclosure: None. This article was originally published at Insider Monkey.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading...